Mayo clinic launches IBD biobank to unlock disease secrets
NCT ID NCT03756649
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is collecting blood, stool, and urine samples from 1,000 people with Inflammatory Bowel Disease (IBD). Researchers will store these samples along with medical information to learn more about the disease and find ways to improve patient outcomes. The study does not involve any treatment or medication.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict how kids with IBD will respond to treatment?
- Can a milk sugar tame IBD symptoms?
- Could an extra flu shot shield vulnerable kids?
- Amniotic cell secretions may fight gut inflammation and scarring — a lab study puts them to the test
- Could a diet change calm IBD by reshaping gut bacteria?
- Can a peer coach help young people take control of their chronic illness?